Violation Tracker Individual Record

Company: 
GeneScience Pharmaceutical Company
Penalty: 
$7,500,000
Year: 
2010
Date: 
October 6, 2010
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

A Chinese drug manufacturer and its CEO pleaded guilty to illegally marketing human growth hormone in the U.S. They jointly forfeited $4.5 million as a result of the criminal charges and agreed to pay an additional $3,000,000 to finance a Clean Competition Fund designed to counter the effects of illicit doping in sports.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
U.S. Attorney-District of Rhode Island
Civil or Criminal Case: 
criminal
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.